Foundations of Malaysian patent law shape how an invention is assessed, claimed and disclosed. Read these five articles on patentability, medical products, novelty, inventive step and technical disclosure, then follow the related guides to explore each topic in more detail.
Adapted from a manuscript by Lawrence Yip.
General information, not legal advice. These articles reflect the supplied editorial collection and its citation audit; check current law and the original authorities before relying on them.
A Valuable Idea Is Not Necessarily a Patentable Invention
A useful commercial idea and a patentable invention are not interchangeable. Malaysian law first asks whether the subject matter provides a practical solution to a specific technological problem. It then applies distinct requirements of novelty, inventive step and industrial applicability.[1]
Consider a proposal for a faster coffee machine. The desired speed identifies a business objective, not the technical means of achieving it. A particular heating arrangement or coordinated processing mechanism may identify an invention capable of legal assessment. The application must explain that arrangement rather than rely on the attractiveness of its result.
Industrial applicability does not require proof that the product will be profitable. Conversely, strong sales cannot establish novelty or inventive step. A conventional machine may be commercially successful and readily manufactured while remaining outside the scope of patent protection.
The practical lesson is to maintain two separate assessments: what the technology contributes, and whether the market values it. A sound commercial forecast cannot repair an absent technical contribution. Equally, a legally promising invention still requires a realistic commercial plan. Neither assessment should be used as a substitute for the other.
Sources and case references
- Patents Act 1983 (Act 291) (Malaysia), sections 11–16.
Medical Methods and Medical Products: Different Patent Questions
A medical procedure and the apparatus used to perform it do not necessarily receive the same treatment under Malaysian patent law. Section 13(1)(d) excludes specified surgical, therapeutic and diagnostic methods practised on the human or animal body. Its proviso preserves the possibility of protection for products used in those methods.[2]
A claim directed to treating a patient must therefore be distinguished from a claim defining the construction of a medical device. A sophisticated device does not make an excluded treatment method patentable. Conversely, using an apparatus in treatment does not automatically exclude the apparatus itself.
The distinction depends on the subject matter actually claimed. Merely changing a heading from “method” to “system” will not establish an eligible technical invention. The claims and supporting disclosure must identify the product’s relevant features and their operation.
Escaping the medical-method exclusion is only the first stage. The product must still satisfy novelty, inventive step and industrial applicability. For inventors, the useful question is not simply whether the invention concerns healthcare, but whether the proposed protection accurately identifies a qualifying product rather than an excluded medical activity.
Sources and case references
- Patents Act 1983 (Act 291) (Malaysia), section 13(1)(d) and proviso; sections 11–16.
Novelty Cannot Be Assembled from Unrelated Disclosures
A novelty objection must identify an earlier disclosure of the claimed invention, not reconstruct it from unrelated technical fragments. The distinction between anticipation and an inventive-step challenge is illustrated by General Tire & Rubber Co v Firestone Tyre & Rubber Co Ltd[3].
Suppose a claim requires components A and B operating in a defined relationship. One earlier document discloses A; another discloses B. Unless a qualifying disclosure makes the complete claimed arrangement available, placing the documents side by side does not establish anticipation. Whether the skilled person would have combined their teachings is a separate question of obviousness.
“Single disclosure” is more accurate than “single document”. Several records may prove what one public demonstration revealed. That evidential exercise is different from combining distinct technical teachings to manufacture an anticipating arrangement.
Timing also matters. A technically identical publication issued too late does not establish earlier public disclosure merely because it resembles the claim. The challenger must establish both the legally relevant availability of the material and the technical information it disclosed.
A useful novelty analysis therefore maps each claimed feature and relationship to the same qualifying disclosure. Missing features should not be supplied through hindsight or an unacknowledged shift into inventive-step reasoning.
Sources and case references
- General Tire & Rubber Co v Firestone Tyre & Rubber Co Ltd [1972] RPC 457 (Court of Appeal, England and Wales).
Inventive Step Requires a View from Before the Invention
An invention can appear straightforward once its solution is known. Patent law must resist that retrospective perspective. In Spind Malaysia Sdn Bhd v Justrade Marketing Sdn Bhd & Ors[4], the Federal Court adopted a structured approach to determining obviousness under section 15 of the Patents Act 1983.
The inquiry identifies the inventive concept, adopts the knowledge of the ordinarily skilled person at the relevant date, identifies differences from the prior art and asks whether those differences would have been obvious without knowledge of the claimed invention.
The skilled person is a legal reference point, not the actual inventor endowed with the inventor’s achievement. Likewise, common general knowledge is not equivalent to everything that could theoretically have been found in a database. The technical assumptions attributed to that person need an evidential foundation.
The practical difficulty often lies in explaining the final step. Demonstrating that individual components were known does not explain why they would have been combined in the claimed relationship. Conversely, the absence of one identical disclosure does not prove inventiveness.
A persuasive opinion reconstructs the earlier technical problem and available knowledge. It does not begin with the completed invention and work backwards until every step appears inevitable.
Sources and case references
- Spind Malaysia Sdn Bhd v Justrade Marketing Sdn Bhd & Ors [2018] 2 MLRA 281 (Federal Court, Malaysia).
Disclosure Is the Price of the Patent Right
Patent protection requires an applicant to teach the invention, not merely announce a desirable outcome. The description must be sufficiently clear and complete for a person having ordinary skill in the art to understand, evaluate and carry out the invention. The claims identify the technical subject matter for which protection is sought.[5]
This division of work matters. A broad claim unsupported by an operative technical explanation does not become stronger because the commercial product is impressive. Nor can an applicant demand exclusivity while withholding the mechanism needed to reproduce the claimed solution.
The disclosure decision should therefore be made deliberately. Patent protection places technical teaching into the public record through the statutory system. Trade secrecy follows a different logic: its value depends on maintaining confidentiality. A business must assess which information it is prepared to disclose and which protection strategy suits the technology.
The central drafting question is whether the specification communicates the actual solution across the scope claimed. Marketing language, attractive drawings and statements of expected benefits cannot replace that teaching. A defensible patent begins with a technically complete explanation, because the exclusive right must be supported by what the applicant has genuinely disclosed.
Sources and case references
- Patents Regulations 1986, P.U. (A) 327/1986 (Malaysia), as amended, regulations 12(1)(c) and 13(1), (5).
Practical questions about this patent chapter
Where should I start when assessing an invention?
Start by separating the commercial objective from the technical solution. A product can be valuable to customers without meeting the requirements discussed in these articles. Read the patentability article first, then work through novelty, inventive step and disclosure. The sequence helps you identify which question you are answering instead of using sales potential as a substitute for a technical or legal assessment.
Do novelty and inventive step mean the same thing?
No. Article 1.3 explains why a novelty comparison looks for the claimed arrangement in a qualifying earlier disclosure. Article 1.4 addresses the different question of whether the differences from prior art would have been obvious to the skilled person at the relevant date. Keep the two inquiries separate when organizing a review. For further reading, explore the chapter on novelty and inventive-step challenges.
Why does a healthcare invention need careful claim language?
The medical-product article distinguishes a treatment method from the product used to carry it out. It also explains that avoiding a method exclusion does not, by itself, establish novelty or inventive step. The useful starting point is the subject matter actually claimed, supported by the technical disclosure. Read the patent claim drafting chapter to continue exploring how claims define the proposed protection.
What information helps when preparing the technical disclosure?
Organize the technical problem, the features of the proposed solution and the way those features operate together. The disclosure article explains why an attractive outcome cannot replace a complete technical explanation. Review the relationship between the description and the scope of the claims, including what the application would disclose publicly. If you need help presenting that explanation, see TRADEMARK2U's patent drafting services.
How can I continue after this chapter?
These articles address Malaysian law. Continue with the chapter on patent applications in Malaysia and abroad to connect the foundational topics with filing routes. TRADEMARK2U supports clients in Malaysia, Indonesia, Thailand, Hong Kong and China. Cross-border planning should consider the rules and filing options relevant to each intended market rather than assume one country's approach applies everywhere.

